165 related articles for article (PubMed ID: 35224157)
1. The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma.
Zhang C; Wang F; Sun N; Zhang Z; Zhang G; Zhang Z; Luo Y; Che Y; Cheng H; Li J; He J
Genes Dis; 2022 Mar; 9(2):415-428. PubMed ID: 35224157
[TBL] [Abstract][Full Text] [Related]
2. An immune checkpoint-based signature predicts prognosis and chemotherapy response for patients with small cell lung cancer.
Wang L; Wu P; Shen Z; Yu Q; Zhang Y; Ye F; Chen K; Zhao J
Int Immunopharmacol; 2023 Apr; 117():109827. PubMed ID: 36989973
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes.
Zhang C; Luo Y; Zhang Z; Zhang Z; Zhang G; Wang F; Che Y; Fang L; Zhang Y; Sun N; He J
Front Cell Dev Biol; 2020; 8():580005. PubMed ID: 33392181
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
5. Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma.
Li Y; Lu Z; Che Y; Wang J; Sun S; Huang J; Mao S; Lei Y; Chen Z; He J
Oncoimmunology; 2017; 6(11):e1356147. PubMed ID: 29147607
[TBL] [Abstract][Full Text] [Related]
6. A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.
Zheng S; Luo X; Dong C; Zheng D; Xie J; Zhuge L; Sun Y; Chen H
Int J Cancer; 2018 Nov; 143(10):2592-2601. PubMed ID: 30152019
[TBL] [Abstract][Full Text] [Related]
7. HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.
Cheng H; Janakiram M; Borczuk A; Lin J; Qiu W; Liu H; Chinai JM; Halmos B; Perez-Soler R; Zang X
Clin Cancer Res; 2017 Feb; 23(3):825-832. PubMed ID: 27553831
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma.
Zhu Z; Dong W
Onco Targets Ther; 2018; 11():1563-1570. PubMed ID: 29593422
[TBL] [Abstract][Full Text] [Related]
9. A B7-CD28 Family-Based Signature Demonstrates Significantly Different Prognosis and Immunological Characteristics in Diffuse Gliomas.
Deng X; Chen K; Ren J; Zeng J; Zhang Q; Li T; Tang Q; Zhu J
Front Mol Biosci; 2022; 9():849723. PubMed ID: 35928223
[TBL] [Abstract][Full Text] [Related]
10. A Multi-Center Validated Subtyping Model of Esophageal Cancer Based on Three Metabolism-Related Genes.
Liu Y; Wang L; Fang L; Liu H; Tian H; Zheng Y; Fan T; Li C; He J
Front Oncol; 2021; 11():772145. PubMed ID: 34760709
[TBL] [Abstract][Full Text] [Related]
11. KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy.
Li Y; Lv C; Yu Y; Wu B; Zhang Y; Lang Q; Liang Z; Zhong C; Shi Y; Han S; Xu F; Tian Y
J Adv Res; 2023 May; 47():137-150. PubMed ID: 35933091
[TBL] [Abstract][Full Text] [Related]
12. A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment.
Gao J; Tang T; Zhang B; Li G
Front Oncol; 2021; 11():603634. PubMed ID: 33718151
[TBL] [Abstract][Full Text] [Related]
13. ICOSLG-associated immunological landscape and diagnostic value in oral squamous cell carcinoma: a prospective cohort study.
Dong Y; Hu X; Xie S; Song Y; He Y; Jin W; Ni Y; Wang Z; Ding L
Front Cell Dev Biol; 2023; 11():1257314. PubMed ID: 37842091
[No Abstract] [Full Text] [Related]
14. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
[TBL] [Abstract][Full Text] [Related]
15. B7 score and T cell infiltration stratify immune status in prostate cancer.
Zhou Q; Li K; Lai Y; Yao K; Wang Q; Zhan X; Peng S; Cai W; Yao W; Zang X; Xu K; Huang J; Huang H
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34417325
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma.
Liu Y; Wang L; Liu H; Li C; He J
Front Oncol; 2020; 10():61. PubMed ID: 32133283
[No Abstract] [Full Text] [Related]
17. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY
J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248
[TBL] [Abstract][Full Text] [Related]
18. Immune-Related Long Non-coding RNA Signature and Clinical Nomogram to Evaluate Survival of Patients Suffering Esophageal Squamous Cell Carcinoma.
Zhu T; Ma Z; Wang H; Wei D; Wang B; Zhang C; Fu L; Li Z; Yu G
Front Cell Dev Biol; 2021; 9():641960. PubMed ID: 33748133
[TBL] [Abstract][Full Text] [Related]
19. B7-H4 and HHLA2, members of B7 family, are aberrantly expressed in EGFR mutated lung adenocarcinoma.
Chen Y; Hu R; Li X; Shi Z; Tian H; Feng J; Yu S
Pathol Res Pract; 2020 Oct; 216(10):153134. PubMed ID: 32853956
[TBL] [Abstract][Full Text] [Related]
20. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.
Janakiram M; Shah UA; Liu W; Zhao A; Schoenberg MP; Zang X
Immunol Rev; 2017 Mar; 276(1):26-39. PubMed ID: 28258693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
